Works matching IS 14628902 AND DT 2025 AND VI 27 AND IP 3
Results: 69
Correction to "Effect of semaglutide 2.4 mg on physical functioning and weight‐ and health‐related quality of life in adults with overweight or obesity: Patient‐reported outcomes from the STEP 1–4 trials".
- Published in:
- 2025
- Publication type:
- Correction Notice
Correction to "Long‐term safety and efficacy of glucagon‐like peptide‐1 receptor agonists in individuals with obesity and without type 2 diabetes: A global retrospective cohort study".
- Published in:
- 2025
- Publication type:
- Correction Notice
A preliminary randomized trial of a brief dissonance‐based type 2 diabetes prevention programme for adults with pre‐diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1572, doi. 10.1111/dom.16170
- By:
- Publication type:
- Article
Impact of the timing of metformin administration on the plasma lactate response to intraduodenal glucose infusion in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1614, doi. 10.1111/dom.16169
- By:
- Publication type:
- Article
Long‐term health benefit and economic return of time in range (TIR) improvement in individuals with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1564, doi. 10.1111/dom.16168
- By:
- Publication type:
- Article
Impact of caloric restriction on diabetes remission in Korean adults with obesity (CREDO‐K study).
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1609, doi. 10.1111/dom.16166
- By:
- Publication type:
- Article
Risk acceleration by gout on major adverse cardiovascular events and all‐cause death in patients with diabetes and chronic kidney disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1554, doi. 10.1111/dom.16165
- By:
- Publication type:
- Article
Treatment outcomes with oral anti‐hyperglycaemic therapies in people with diabetes secondary to a pancreatic condition (type 3c diabetes): A population‐based cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1544, doi. 10.1111/dom.16163
- By:
- Publication type:
- Article
Weight loss and body composition after compounded semaglutide treatment in a real world setting.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1536, doi. 10.1111/dom.16162
- By:
- Publication type:
- Article
Effectiveness and safety of iGlarLixi in people with type 2 diabetes not at target on basal insulin and oral antidiabetic therapy in a prospective observational trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1526, doi. 10.1111/dom.16161
- By:
- Publication type:
- Article
Predictive models of post‐prandial glucose response in persons with prediabetes and early onset type 2 diabetes: A pilot study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1515, doi. 10.1111/dom.16160
- By:
- Publication type:
- Article
Greater improvement in insulin sensitivity per unit weight loss associated with tirzepatide versus semaglutide: An exploratory analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1507, doi. 10.1111/dom.16159
- By:
- Publication type:
- Article
Sustained weight reduction following 12 weeks of intermittent fasting intervention in people with insulin‐treated type 2 diabetes—Two‐year follow‐up of the randomised controlled InterFast‐2 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1605, doi. 10.1111/dom.16158
- By:
- Publication type:
- Article
Efficacy of imeglimin in patients with type 2 diabetes mellitus complicated by metabolic dysfunction‐associated steatotic liver disease: A multicentre study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1498, doi. 10.1111/dom.16157
- By:
- Publication type:
- Article
Ceramide‐based risk score CERT‐1 improves risk prediction for overall mortality and adverse cardiovascular outcomes in patients with and without cardiovascular disease: A prospective cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1488, doi. 10.1111/dom.16156
- By:
- Publication type:
- Article
Beta cell function and global glucose metabolism are impaired in Dp(16)1Yey mouse model of Down syndrome.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1477, doi. 10.1111/dom.16155
- By:
- Publication type:
- Article
Metabolic interventions as adjunctive therapies to insulin in type 1 diabetes: Current clinical landscape and perspectives.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1032, doi. 10.1111/dom.16154
- By:
- Publication type:
- Article
Minimum expectations for market authorization of continuous glucose monitoring devices in Europe—'eCGM' compliance status.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1025, doi. 10.1111/dom.16153
- By:
- Publication type:
- Article
Glucagon‐like peptide‐1 analogues reduce alcohol intake.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1601, doi. 10.1111/dom.16152
- By:
- Publication type:
- Article
Glucagon‐like peptide‐1 receptor agonists discontinuation is higher in individuals with overweight and obesity without type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1597, doi. 10.1111/dom.16151
- By:
- Publication type:
- Article
Efficacy of imeglimin treatment versus metformin dose escalation on glycemic control in subjects with type 2 diabetes treated with a dipeptidyl peptidase‐4 inhibitor plus low‐dose metformin: A multicenter, prospective, randomized, open‐label, parallel‐group comparison study (MEGMI study)
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1466, doi. 10.1111/dom.16150
- By:
- Publication type:
- Article
Effectiveness of add‐on therapy with SGLT2 inhibitors or GLP‐1 receptor agonists in adults with type 1 diabetes: A prospective DPV registry study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1591, doi. 10.1111/dom.16149
- By:
- Publication type:
- Article
The cardio‐metabolic protein profile is associated with development of type 2 diabetes at long term follow‐up after gestational diabetes mellitus: Results from the OGFUS study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1456, doi. 10.1111/dom.16148
- By:
- Publication type:
- Article
Assessing the benefit–risk profile of newer glucose‐lowering drugs: A systematic review and network meta‐analysis of randomized outcome trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1444, doi. 10.1111/dom.16147
- By:
- Publication type:
- Article
Heterogeneous blood pressure treatment effects on cognitive decline in type 2 diabetes: A machine learning analysis of a randomized clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1432, doi. 10.1111/dom.16145
- By:
- Publication type:
- Article
Efficacy and safety of switching to insulin glargine 300 U/mL in people with type 2 diabetes uncontrolled on basal insulin in China: A post hoc subpopulation analysis of the INITIATION study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1423, doi. 10.1111/dom.16144
- By:
- Publication type:
- Article
Association between time in tight range and incident diabetic retinopathy in adults with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1415, doi. 10.1111/dom.16143
- By:
- Publication type:
- Article
Diagnostic accuracy of Agile‐4 score for liver cirrhosis in patients with metabolic dysfunction‐associated steatotic liver disease. A systematic review and meta‐analysis of diagnostic test accuracy studies.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1406, doi. 10.1111/dom.16142
- By:
- Publication type:
- Article
Paediatric‐to‐adult transition in type 1 diabetes: A two‐centre experience of a structured program, 2014 to 2022.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1397, doi. 10.1111/dom.16140
- By:
- Publication type:
- Article
Improved glycaemic control in people with type 2 diabetes initiating or switching to IDegAsp in a real‐world setting in China.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1388, doi. 10.1111/dom.16139
- By:
- Publication type:
- Article
Reply to the Letters by Louie and Pereira et al.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1622, doi. 10.1111/dom.16138
- By:
- Publication type:
- Article
Exclusion of older persons from randomized controlled trials in type 2 diabetes: A cross‐sectional study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1379, doi. 10.1111/dom.16137
- By:
- Publication type:
- Article
Impact of weight change on kidney transplantation outcomes: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1369, doi. 10.1111/dom.16135
- By:
- Publication type:
- Article
When can weekly anti‐obesity peptides be used for monthly administration?
- Published in:
- 2025
- By:
- Publication type:
- Abstract
Heart failure phenotypes in people with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1588, doi. 10.1111/dom.16133
- By:
- Publication type:
- Article
The predictive value of estimated glucose disposal rate and its association with myocardial infarction, heart failure, atrial fibrillation and ischemic stroke.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1359, doi. 10.1111/dom.16132
- By:
- Publication type:
- Article
Prevalence of MASLD in children and adolescents with type 1 diabetes: A meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1584, doi. 10.1111/dom.16125
- By:
- Publication type:
- Article
Investigating the common genetic architecture and causality of metabolic disorders with neurodegenerative diseases.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1337, doi. 10.1111/dom.16130
- By:
- Publication type:
- Article
Metformin lowers risk of hearing loss and mortality in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1327, doi. 10.1111/dom.16128
- By:
- Publication type:
- Article
Effects of sodium‐glucose cotransporter‐2 inhibitors in myocardial infarction patients: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1276, doi. 10.1111/dom.16122
- By:
- Publication type:
- Article
Chemerin loss‐of‐function attenuates glucagon‐like peptide‐1 secretion in exercised obese mice.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1296, doi. 10.1111/dom.16126
- By:
- Publication type:
- Article
Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double‐blind, randomized, placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1350, doi. 10.1111/dom.16131
- By:
- Publication type:
- Article
A comment on "Metformin in the Diabetes Prevention Program 3‐year trial: The cost‐effectiveness that never was".
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1626, doi. 10.1111/dom.16124
- By:
- Publication type:
- Article
Type 2 diabetes genetic risk and incident diabetes across diabetes risk enhancers.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1287, doi. 10.1111/dom.16123
- By:
- Publication type:
- Article
IDOL alleviates the body weight by upregulating UCP‐1 in mice.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1314, doi. 10.1111/dom.16127
- By:
- Publication type:
- Article
The effect of HbA1c variability on the efficacy of intensive blood pressure control in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1208, doi. 10.1111/dom.16112
- By:
- Publication type:
- Article
Identifying subgroups benefiting from intensive glycaemic treatment to improve renal outcomes in type 2 diabetes: Insights from the ACCORD trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1198, doi. 10.1111/dom.16111
- By:
- Publication type:
- Article
Identification of adipose tissue‐derived exosomal microRNA as a novel causal biomarker for cognitive impairment in type 2 diabetes mellitus: Triangulating evidence from Mendelian randomization and multicentre population studies.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1265, doi. 10.1111/dom.16121
- By:
- Publication type:
- Article
Precision medicine in type 1 diabetes: comparing metabolic outcomes of Control‐IQ and MiniMed 780G according to patient characteristics.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1233, doi. 10.1111/dom.16118
- By:
- Publication type:
- Article
Effect of introduction of intermittently scanned continuous glucose monitoring on glycaemic control in individuals living with type 2 diabetes mellitus treated with non‐insulin therapies—A randomised controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1226, doi. 10.1111/dom.16116
- By:
- Publication type:
- Article